Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 9 | 2019 | 783 | 1.710 |
Why?
|
Ventricular Remodeling | 26 | 2011 | 1222 | 1.600 |
Why?
|
Matrix Metalloproteinases | 14 | 2011 | 391 | 1.400 |
Why?
|
Matrix Metalloproteinase 9 | 9 | 2010 | 637 | 0.850 |
Why?
|
Myocardial Contraction | 12 | 2009 | 1585 | 0.770 |
Why?
|
Myocardium | 23 | 2011 | 4788 | 0.760 |
Why?
|
Myocardial Infarction | 23 | 2011 | 11668 | 0.710 |
Why?
|
Ventricular Function, Left | 15 | 2011 | 3620 | 0.690 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 9 | 2011 | 99 | 0.660 |
Why?
|
Matrix Metalloproteinase 2 | 10 | 2010 | 472 | 0.590 |
Why?
|
Heart Arrest, Induced | 4 | 2006 | 355 | 0.590 |
Why?
|
Matrix Metalloproteinase 14 | 7 | 2011 | 60 | 0.580 |
Why?
|
Glutens | 2 | 2015 | 230 | 0.540 |
Why?
|
Myocardial Reperfusion Injury | 5 | 2009 | 476 | 0.430 |
Why?
|
Endopeptidases | 1 | 2015 | 771 | 0.400 |
Why?
|
Immunomodulation | 1 | 2015 | 540 | 0.390 |
Why?
|
Diet, Gluten-Free | 4 | 2019 | 271 | 0.380 |
Why?
|
Myocytes, Cardiac | 8 | 2010 | 1625 | 0.380 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 4 | 2005 | 149 | 0.360 |
Why?
|
Swine | 21 | 2011 | 5901 | 0.350 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8605 | 0.350 |
Why?
|
Duodenum | 1 | 2012 | 481 | 0.350 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2010 | 235 | 0.340 |
Why?
|
Endotoxins | 1 | 2010 | 524 | 0.320 |
Why?
|
Finite Element Analysis | 1 | 2010 | 431 | 0.310 |
Why?
|
Endothelin-1 | 2 | 2006 | 313 | 0.300 |
Why?
|
Models, Cardiovascular | 2 | 2010 | 997 | 0.300 |
Why?
|
Heart Conduction System | 2 | 2010 | 1049 | 0.290 |
Why?
|
Oligopeptides | 4 | 2015 | 1179 | 0.290 |
Why?
|
Aorta, Thoracic | 6 | 2010 | 1078 | 0.280 |
Why?
|
Fibrinolysin | 3 | 2011 | 132 | 0.280 |
Why?
|
Aortic Aneurysm, Thoracic | 6 | 2010 | 678 | 0.280 |
Why?
|
Aprotinin | 3 | 2011 | 88 | 0.270 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2005 | 134 | 0.260 |
Why?
|
Animals, Newborn | 1 | 2010 | 2732 | 0.250 |
Why?
|
Cytokines | 5 | 2017 | 7298 | 0.250 |
Why?
|
Protein Kinase C | 2 | 2006 | 1223 | 0.250 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2004 | 68 | 0.250 |
Why?
|
Transcription, Genetic | 3 | 2010 | 7709 | 0.250 |
Why?
|
Electric Stimulation Therapy | 1 | 2010 | 604 | 0.240 |
Why?
|
Heart-Assist Devices | 3 | 2010 | 1191 | 0.240 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2010 | 852 | 0.240 |
Why?
|
Radiation Injuries, Experimental | 1 | 2003 | 91 | 0.230 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2011 | 981 | 0.230 |
Why?
|
Heart Injuries | 1 | 2005 | 210 | 0.230 |
Why?
|
Antifibrinolytic Agents | 3 | 2010 | 251 | 0.230 |
Why?
|
Muscle Cells | 1 | 2004 | 196 | 0.230 |
Why?
|
Hydroxamic Acids | 2 | 2003 | 495 | 0.220 |
Why?
|
Intestinal Mucosa | 2 | 2017 | 3036 | 0.220 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2002 | 246 | 0.200 |
Why?
|
Heart | 4 | 2011 | 4466 | 0.200 |
Why?
|
Enzyme Activation | 6 | 2010 | 3701 | 0.200 |
Why?
|
Random Allocation | 7 | 2010 | 2417 | 0.200 |
Why?
|
Microdialysis | 6 | 2011 | 158 | 0.200 |
Why?
|
Temperature | 2 | 2006 | 2202 | 0.190 |
Why?
|
Arrhythmias, Cardiac | 2 | 2010 | 2265 | 0.190 |
Why?
|
Enzyme Inhibitors | 5 | 2005 | 3802 | 0.190 |
Why?
|
Ventricular Pressure | 3 | 2010 | 199 | 0.180 |
Why?
|
Biocompatible Materials | 1 | 2008 | 1730 | 0.180 |
Why?
|
Animals | 50 | 2011 | 168368 | 0.180 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2010 | 191 | 0.170 |
Why?
|
Serine Proteinase Inhibitors | 2 | 2011 | 179 | 0.170 |
Why?
|
Disease Models, Animal | 18 | 2010 | 18003 | 0.170 |
Why?
|
Enzyme Induction | 4 | 2006 | 475 | 0.160 |
Why?
|
Collagen | 10 | 2011 | 2671 | 0.160 |
Why?
|
Tranexamic Acid | 2 | 2010 | 144 | 0.160 |
Why?
|
Isoenzymes | 4 | 2006 | 1720 | 0.150 |
Why?
|
Cardiopulmonary Bypass | 3 | 2010 | 1064 | 0.150 |
Why?
|
Hemodynamics | 10 | 2010 | 4197 | 0.150 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2010 | 1213 | 0.140 |
Why?
|
Promoter Regions, Genetic | 5 | 2010 | 5863 | 0.140 |
Why?
|
Computer Simulation | 1 | 2010 | 6237 | 0.140 |
Why?
|
Hookworm Infections | 1 | 2015 | 13 | 0.130 |
Why?
|
Caspases | 3 | 2010 | 927 | 0.130 |
Why?
|
Endothelins | 2 | 2006 | 138 | 0.130 |
Why?
|
Echocardiography | 6 | 2010 | 5098 | 0.130 |
Why?
|
Rewarming | 2 | 2004 | 60 | 0.120 |
Why?
|
Cardioplegic Solutions | 2 | 2004 | 118 | 0.120 |
Why?
|
Irritable Bowel Syndrome | 1 | 2020 | 441 | 0.120 |
Why?
|
Peptides | 2 | 2006 | 4395 | 0.120 |
Why?
|
Transglutaminases | 1 | 2015 | 193 | 0.120 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 418 | 0.120 |
Why?
|
Catheter Ablation | 2 | 2005 | 2737 | 0.120 |
Why?
|
Enterocytes | 1 | 2015 | 225 | 0.120 |
Why?
|
Heart Failure | 5 | 2010 | 10793 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2010 | 2044 | 0.110 |
Why?
|
Alanine Transaminase | 1 | 2015 | 591 | 0.110 |
Why?
|
Tight Junctions | 1 | 2015 | 310 | 0.110 |
Why?
|
Fibroblasts | 4 | 2010 | 4137 | 0.100 |
Why?
|
Fibrinolysis | 2 | 2010 | 322 | 0.100 |
Why?
|
Mice | 20 | 2011 | 81002 | 0.100 |
Why?
|
Heart Ventricles | 7 | 2010 | 3799 | 0.100 |
Why?
|
Probiotics | 1 | 2015 | 350 | 0.100 |
Why?
|
Sus scrofa | 3 | 2010 | 437 | 0.100 |
Why?
|
Protease Inhibitors | 2 | 2006 | 792 | 0.090 |
Why?
|
GTP-Binding Proteins | 1 | 2015 | 972 | 0.090 |
Why?
|
Durapatite | 1 | 2011 | 160 | 0.090 |
Why?
|
Heart Rate | 3 | 2010 | 4095 | 0.090 |
Why?
|
Systole | 2 | 2010 | 956 | 0.090 |
Why?
|
Diastole | 2 | 2010 | 791 | 0.090 |
Why?
|
Forkhead Transcription Factors | 1 | 2017 | 1602 | 0.090 |
Why?
|
Time Factors | 12 | 2010 | 40050 | 0.090 |
Why?
|
Compliance | 1 | 2009 | 105 | 0.090 |
Why?
|
Acetylcysteine | 1 | 2010 | 273 | 0.090 |
Why?
|
Heart Septal Defects | 1 | 2010 | 192 | 0.090 |
Why?
|
Metalloendopeptidases | 3 | 2005 | 395 | 0.080 |
Why?
|
Calpain | 1 | 2009 | 150 | 0.080 |
Why?
|
Dilatation, Pathologic | 3 | 2010 | 516 | 0.080 |
Why?
|
Microspheres | 1 | 2011 | 778 | 0.080 |
Why?
|
Cardiotonic Agents | 2 | 2009 | 535 | 0.080 |
Why?
|
beta-Galactosidase | 2 | 2006 | 572 | 0.080 |
Why?
|
Thoracotomy | 1 | 2010 | 365 | 0.080 |
Why?
|
Immunohistochemistry | 8 | 2011 | 11347 | 0.080 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2010 | 847 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2017 | 3193 | 0.080 |
Why?
|
Up-Regulation | 4 | 2010 | 4205 | 0.080 |
Why?
|
Injections, Intralesional | 1 | 2008 | 276 | 0.080 |
Why?
|
Microinjections | 1 | 2008 | 326 | 0.080 |
Why?
|
Dipeptides | 1 | 2009 | 409 | 0.070 |
Why?
|
Atrial Fibrillation | 1 | 2006 | 5003 | 0.070 |
Why?
|
Food Hypersensitivity | 1 | 2014 | 613 | 0.070 |
Why?
|
Drug Discovery | 1 | 2015 | 1056 | 0.070 |
Why?
|
Protein Kinase C-epsilon | 1 | 2006 | 43 | 0.070 |
Why?
|
Dogs | 2 | 2010 | 3915 | 0.070 |
Why?
|
Probability | 2 | 2010 | 2500 | 0.070 |
Why?
|
Vaccines | 1 | 2015 | 802 | 0.070 |
Why?
|
Chemokines | 1 | 2010 | 948 | 0.070 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2006 | 58 | 0.070 |
Why?
|
Hemostatics | 1 | 2009 | 228 | 0.070 |
Why?
|
Myocardial Reperfusion | 2 | 2006 | 351 | 0.070 |
Why?
|
Extracellular Matrix | 2 | 2011 | 1734 | 0.070 |
Why?
|
Vasoconstriction | 1 | 2009 | 601 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 1129 | 0.070 |
Why?
|
Stroke Volume | 5 | 2010 | 4941 | 0.070 |
Why?
|
Transforming Growth Factor beta | 2 | 2010 | 1997 | 0.070 |
Why?
|
Connexin 43 | 1 | 2006 | 206 | 0.070 |
Why?
|
Hyperkalemia | 2 | 2004 | 219 | 0.070 |
Why?
|
Mice, Transgenic | 5 | 2010 | 9734 | 0.060 |
Why?
|
Pacemaker, Artificial | 1 | 2010 | 813 | 0.060 |
Why?
|
Isotonic Solutions | 1 | 2004 | 119 | 0.060 |
Why?
|
Male | 28 | 2017 | 349022 | 0.060 |
Why?
|
Sheep | 4 | 2011 | 1434 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2010 | 1025 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 1957 | 0.060 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2003 | 141 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3614 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.060 |
Why?
|
Reference Values | 2 | 2008 | 4983 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7897 | 0.060 |
Why?
|
Depression, Chemical | 1 | 2002 | 191 | 0.060 |
Why?
|
Guanidines | 1 | 2003 | 191 | 0.060 |
Why?
|
Calcium Chloride | 3 | 2010 | 77 | 0.050 |
Why?
|
Endocardium | 1 | 2003 | 261 | 0.050 |
Why?
|
Adrenomedullin | 1 | 2002 | 87 | 0.050 |
Why?
|
Purinergic P1 Receptor Antagonists | 1 | 2002 | 45 | 0.050 |
Why?
|
Radio Waves | 1 | 2003 | 251 | 0.050 |
Why?
|
Gene Deletion | 3 | 2006 | 2757 | 0.050 |
Why?
|
Humans | 21 | 2020 | 739398 | 0.050 |
Why?
|
Recovery of Function | 2 | 2010 | 2924 | 0.050 |
Why?
|
Creatine Kinase | 1 | 2003 | 694 | 0.050 |
Why?
|
Tachycardia, Ventricular | 1 | 2010 | 1271 | 0.050 |
Why?
|
Equipment Design | 1 | 2010 | 3583 | 0.050 |
Why?
|
Latent TGF-beta Binding Proteins | 2 | 2011 | 42 | 0.050 |
Why?
|
Analysis of Variance | 3 | 2010 | 6370 | 0.050 |
Why?
|
Blood Pressure | 4 | 2010 | 8554 | 0.050 |
Why?
|
Sulfones | 1 | 2003 | 436 | 0.050 |
Why?
|
Disease Progression | 7 | 2006 | 13237 | 0.050 |
Why?
|
Female | 20 | 2017 | 378853 | 0.040 |
Why?
|
Aging | 2 | 2009 | 8613 | 0.040 |
Why?
|
Cicatrix | 1 | 2005 | 750 | 0.040 |
Why?
|
Heart Atria | 1 | 2006 | 1342 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2006 | 19220 | 0.040 |
Why?
|
Electrocardiography | 2 | 2010 | 6426 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2010 | 21863 | 0.040 |
Why?
|
Infusions, Intravenous | 3 | 2010 | 2270 | 0.040 |
Why?
|
Protein Transport | 1 | 2005 | 1991 | 0.040 |
Why?
|
Hypothermia, Induced | 1 | 2004 | 746 | 0.040 |
Why?
|
Quadriceps Muscle | 2 | 2010 | 142 | 0.040 |
Why?
|
Fibrosis | 3 | 2010 | 2024 | 0.040 |
Why?
|
Kidney | 4 | 2011 | 7144 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2010 | 14740 | 0.040 |
Why?
|
Organ Size | 1 | 2003 | 2247 | 0.040 |
Why?
|
Ethanol | 1 | 2005 | 1329 | 0.040 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 2 | 2010 | 68 | 0.040 |
Why?
|
Spectrometry, Fluorescence | 2 | 2010 | 691 | 0.040 |
Why?
|
Coronary Artery Bypass | 2 | 2005 | 2272 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2011 | 13002 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17384 | 0.040 |
Why?
|
Caspase 3 | 2 | 2010 | 758 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10534 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 4035 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2002 | 919 | 0.030 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2005 | 1257 | 0.030 |
Why?
|
Area Under Curve | 2 | 2010 | 1655 | 0.030 |
Why?
|
Receptor, Angiotensin, Type 1 | 2 | 2009 | 152 | 0.030 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 311 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2019 | 62693 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2020 | 629 | 0.030 |
Why?
|
Actins | 3 | 2010 | 2112 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2010 | 19811 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 2146 | 0.030 |
Why?
|
Models, Animal | 2 | 2011 | 2164 | 0.030 |
Why?
|
Cell Survival | 1 | 2004 | 5877 | 0.030 |
Why?
|
Stress, Mechanical | 2 | 2009 | 1682 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 527 | 0.030 |
Why?
|
HLA-DQ Antigens | 1 | 2014 | 210 | 0.030 |
Why?
|
Genes, Reporter | 2 | 2009 | 1549 | 0.030 |
Why?
|
Angiotensin II | 2 | 2009 | 880 | 0.030 |
Why?
|
Troponin I | 2 | 2010 | 616 | 0.030 |
Why?
|
Postoperative Period | 2 | 2010 | 1835 | 0.030 |
Why?
|
Mitral Valve Insufficiency | 1 | 2002 | 1408 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2011 | 10945 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2017 | 1725 | 0.030 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2011 | 103 | 0.020 |
Why?
|
Middle Aged | 8 | 2017 | 212863 | 0.020 |
Why?
|
Thallium Radioisotopes | 1 | 2011 | 139 | 0.020 |
Why?
|
Smad2 Protein | 1 | 2011 | 156 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4743 | 0.020 |
Why?
|
Survival | 1 | 2011 | 162 | 0.020 |
Why?
|
Fibrillar Collagens | 1 | 2010 | 40 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 1004 | 0.020 |
Why?
|
Ultrasonography | 3 | 2010 | 5941 | 0.020 |
Why?
|
Intestine, Small | 1 | 2017 | 1242 | 0.020 |
Why?
|
Calcium | 1 | 2003 | 5742 | 0.020 |
Why?
|
Th17 Cells | 1 | 2017 | 760 | 0.020 |
Why?
|
Gelatinases | 1 | 2010 | 94 | 0.020 |
Why?
|
Enzyme Precursors | 1 | 2010 | 176 | 0.020 |
Why?
|
Coronary Disease | 1 | 2005 | 6068 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1820 | 0.020 |
Why?
|
Microbubbles | 1 | 2010 | 128 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 2999 | 0.020 |
Why?
|
Lac Operon | 1 | 2009 | 238 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 11699 | 0.020 |
Why?
|
Microscopy, Confocal | 2 | 2005 | 1967 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2015 | 1645 | 0.020 |
Why?
|
Myosins | 1 | 2010 | 408 | 0.020 |
Why?
|
Injections | 1 | 2011 | 837 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2010 | 6610 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2009 | 664 | 0.020 |
Why?
|
Mice, Knockout | 3 | 2011 | 14558 | 0.020 |
Why?
|
Elastin | 1 | 2009 | 305 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20055 | 0.020 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2010 | 425 | 0.020 |
Why?
|
Chronic Disease | 1 | 2003 | 9133 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3382 | 0.020 |
Why?
|
Apoptosis | 3 | 2009 | 9714 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2009 | 1421 | 0.020 |
Why?
|
Elasticity | 1 | 2009 | 656 | 0.020 |
Why?
|
Signal Transduction | 4 | 2011 | 23355 | 0.020 |
Why?
|
Adult | 5 | 2017 | 213394 | 0.020 |
Why?
|
Microscopy, Video | 1 | 2006 | 245 | 0.020 |
Why?
|
Troponin | 1 | 2010 | 516 | 0.020 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2005 | 49 | 0.020 |
Why?
|
Electric Conductivity | 1 | 2006 | 411 | 0.020 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2005 | 18 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-3 | 1 | 2005 | 35 | 0.020 |
Why?
|
Gap Junctions | 1 | 2006 | 233 | 0.020 |
Why?
|
Aged | 5 | 2017 | 162698 | 0.020 |
Why?
|
Heart Block | 1 | 2006 | 410 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2011 | 965 | 0.020 |
Why?
|
Organ Specificity | 1 | 2009 | 2004 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2881 | 0.020 |
Why?
|
Liver | 2 | 2010 | 7449 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2005 | 547 | 0.010 |
Why?
|
Heart Septum | 1 | 2005 | 313 | 0.010 |
Why?
|
Age Factors | 2 | 2013 | 18349 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3510 | 0.010 |
Why?
|
Adrenergic beta-Agonists | 1 | 2004 | 346 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2017 | 2986 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2015 | 21694 | 0.010 |
Why?
|
Creatine Kinase, MB Form | 1 | 2003 | 214 | 0.010 |
Why?
|
Electrolytes | 1 | 2004 | 282 | 0.010 |
Why?
|
Benzenesulfonates | 1 | 2003 | 169 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1925 | 0.010 |
Why?
|
Hematologic Tests | 1 | 2004 | 237 | 0.010 |
Why?
|
Heart Function Tests | 1 | 2003 | 331 | 0.010 |
Why?
|
Chymases | 1 | 2002 | 99 | 0.010 |
Why?
|
Angiotensin I | 1 | 2002 | 56 | 0.010 |
Why?
|
Alabama | 1 | 2002 | 97 | 0.010 |
Why?
|
Rabbits | 1 | 2009 | 4882 | 0.010 |
Why?
|
Cell Hypoxia | 1 | 2005 | 676 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5181 | 0.010 |
Why?
|
Xanthines | 1 | 2002 | 121 | 0.010 |
Why?
|
Endosomes | 1 | 2005 | 527 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15511 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2006 | 915 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3609 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2004 | 15194 | 0.010 |
Why?
|
Immunoblotting | 1 | 2005 | 1683 | 0.010 |
Why?
|
Kinetics | 1 | 2009 | 6475 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6516 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2006 | 1504 | 0.010 |
Why?
|
Renin | 1 | 2002 | 637 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8669 | 0.010 |
Why?
|
Biological Transport | 1 | 2003 | 2118 | 0.010 |
Why?
|
Neurotransmitter Agents | 1 | 2003 | 646 | 0.010 |
Why?
|
Cell Communication | 1 | 2006 | 1618 | 0.010 |
Why?
|
Cell Separation | 1 | 2004 | 1739 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10398 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2005 | 1871 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 12640 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12948 | 0.010 |
Why?
|
Young Adult | 2 | 2017 | 56255 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6237 | 0.010 |
Why?
|
Infant | 2 | 2010 | 34923 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2003 | 1637 | 0.010 |
Why?
|
Coronary Circulation | 1 | 2003 | 1578 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2003 | 1374 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 4400 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2006 | 2864 | 0.010 |
Why?
|
Contrast Media | 1 | 2010 | 5293 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2002 | 1070 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2003 | 1128 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2015 | 76631 | 0.010 |
Why?
|
Gene Expression | 1 | 2009 | 7788 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15153 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2011 | 4920 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 1510 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 2004 | 1909 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13816 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 8977 | 0.010 |
Why?
|
Protein Binding | 1 | 2006 | 9375 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 13872 | 0.010 |
Why?
|
Survival Analysis | 1 | 2006 | 10247 | 0.010 |
Why?
|
Piperazines | 1 | 2003 | 2480 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 18125 | 0.010 |
Why?
|
Wound Healing | 1 | 2003 | 2768 | 0.010 |
Why?
|
Rats | 1 | 2009 | 24270 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2003 | 2220 | 0.010 |
Why?
|
Macrophages | 1 | 2006 | 5631 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4660 | 0.010 |
Why?
|
Length of Stay | 1 | 2004 | 6295 | 0.010 |
Why?
|
Adolescent | 1 | 2017 | 85405 | 0.010 |
Why?
|
United States | 1 | 2015 | 69573 | 0.000 |
Why?
|
Phenotype | 1 | 2004 | 16301 | 0.000 |
Why?
|
Risk Factors | 1 | 2013 | 71974 | 0.000 |
Why?
|
Prospective Studies | 1 | 2004 | 53037 | 0.000 |
Why?
|